A citation-based method for searching scientific literature

M S Lim, Thomas Beyer, A Babayan, M Bergmann, M Brehme, A Buyx, J Czernin, G Egger, K S J Elenitoba-Johnson, B Gückel, A Jačan, H Haslacher, R J Hicks, L Kenner, M Langanke, M Mitterhauser, B J Pichler, H R Salih, R Schibli, S Schulz, J Simecek, J Simon, M O Soares, U Stelzl, W Wadsak, K Zatloukal, M Zeitlinger, M Hacker. Mol Imaging Biol 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer.
Till Plönes, Walburga Engel-Riedel, Erich Stoelben, Christina Limmroth, Oliver Schildgen, Verena Schildgen. J Pers Med 2016
7
50

Challenges and innovations in personalized medicine care.
Giulia Sedda, Roberto Gasparri, Lorenzo Spaggiari. Future Oncol 2019
1
100

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, Philippe L Bedard, Scott Ernst, Hal Hirte, Sebastien Hotte, Amit Oza, Albiruni Razak, Stephen Welch,[...]. Eur J Hum Genet 2014
62
50

Personalized medicine could transform healthcare.
Sunil Mathur, Joseph Sutton. Biomed Rep 2017
44
50


Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study.
Mojtaba Vaismoradi, Hannele Turunen, Terese Bondas. Nurs Health Sci 2013
50

How Do Patients Experience Individualized Medicine? A Qualitative Interview-based Study of Gene Expression Analyses in the Treatment of Breast Cancer.
Sebastian Schleidgen, Sandra Thiersch, Rachel Wuerstlein, Georg Marckmann. Geburtshilfe Frauenheilkd 2017
3
50

Network analysis for the visualization and analysis of qualitative data.
Jennifer J Pokorny, Alex Norman, Anthony P Zanesco, Susan Bauer-Wu, Baljinder K Sahdra, Clifford D Saron. Psychol Methods 2018
2
50

Biclique: an R package for maximal biclique enumeration in bipartite graphs.
Yuping Lu, Charles A Phillips, Michael A Langston. BMC Res Notes 2020
2
50

Network analysis in the social sciences.
Stephen P Borgatti, Ajay Mehra, Daniel J Brass, Giuseppe Labianca. Science 2009
446
50

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
Stacy W Gray, Katherine Hicks-Courant, Christopher S Lathan, Levi Garraway, Elyse R Park, Jane C Weeks. J Oncol Pract 2012
81
50

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Eric Faulkner, Lieven Annemans, Lou Garrison, Mark Helfand, Anke-Peggy Holtorf, John Hornberger, Dyfrig Hughes, Tracy Li, Daniel Malone, Katherine Payne,[...]. Value Health 2012
77
50

Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
Subha Madhavan, Somasundaram Subramaniam, Thomas D Brown, James L Chen. Am Soc Clin Oncol Educ Book 2018
14
50

Bipartite graphs in systems biology and medicine: a survey of methods and applications.
Georgios A Pavlopoulos, Panagiota I Kontou, Athanasia Pavlopoulou, Costas Bouyioukos, Evripides Markou, Pantelis G Bagos. Gigascience 2018
31
50

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
Nina R Sperber, Janet S Carpenter, Larisa H Cavallari, Laura J Damschroder, Rhonda M Cooper-DeHoff, Joshua C Denny, Geoffrey S Ginsburg, Yue Guan, Carol R Horowitz, Kenneth D Levy,[...]. BMC Med Genomics 2017
57
50


Patient and interest organizations' views on personalized medicine: a qualitative study.
Isabelle Budin-Ljøsne, Jennifer R Harris. BMC Med Ethics 2016
19
50

Ethics, evidence and economics in the pursuit of "personalized medicine".
Jan Lewis, Wendy Lipworth, Ian Kerridge. J Pers Med 2014
7
50

Mixed methods in biomedical and health services research.
Leslie A Curry, Harlan M Krumholz, Alicia O'Cathain, Vicki L Plano Clark, Emily Cherlin, Elizabeth H Bradley. Circ Cardiovasc Qual Outcomes 2013
86
50

Umbrella and basket trials in oncology: ethical challenges.
Karolina Strzebonska, Marcin Waligora. BMC Med Ethics 2019
12
50

The Future of Precision Medicine: Potential Impacts for Health Technology Assessment.
James Love-Koh, Alison Peel, Juan Carlos Rejon-Parrilla, Kate Ennis, Rosemary Lovett, Andrea Manca, Anastasia Chalkidou, Hannah Wood, Matthew Taylor. Pharmacoeconomics 2018
27
50


Personalized medicine in oncology: the future is now.
Richard L Schilsky. Nat Rev Drug Discov 2010
177
50

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Ying-Wei Li, Jian Xu, Guo-Yuan Zhu, Zhu-Juan Huang, Yan Lu, Xian-Qian Li, Neng Wang, Feng-Xue Zhang. Cell Death Discov 2018
40
50

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.
Marian L Burr, Christina E Sparbier, Yih-Chih Chan, James C Williamson, Katherine Woods, Paul A Beavis, Enid Y N Lam, Melissa A Henderson, Charles C Bell, Sabine Stolzenburg,[...]. Nature 2017
308
50

Deglycosylation of PD-L1 by 2-deoxyglucose reverses PARP inhibitor-induced immunosuppression in triple-negative breast cancer.
Bin Shao, Chia-Wei Li, Seung-Oe Lim, Linlin Sun, Yun-Ju Lai, Junwei Hou, Chunxiao Liu, Chiung-Wen Chang, Yufan Qiu, Jung-Mao Hsu,[...]. Am J Cancer Res 2018
25
50

Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
Evelyn Menares, Felipe Gálvez-Cancino, Pablo Cáceres-Morgado, Ehsan Ghorani, Ernesto López, Ximena Díaz, Juan Saavedra-Almarza, Diego A Figueroa, Eduardo Roa, Sergio A Quezada,[...]. Nat Commun 2019
59
50

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
Lu Xu, Yang Zhang, Kang Tian, Xi Chen, Rongxin Zhang, Xindi Mu, Yueguang Wu, Duchuang Wang, Shanshan Wang, Fang Liu,[...]. J Exp Clin Cancer Res 2018
51
50


A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.
Longchuan Bai, Haibin Zhou, Renqi Xu, Yujun Zhao, Krishnapriya Chinnaswamy, Donna McEachern, Jianyong Chen, Chao-Yie Yang, Zhaomin Liu, Mi Wang,[...]. Cancer Cell 2019
129
50

Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
Wen-Jun Wang, Long-Fei Mao, Huan-Ling Lai, Yu-Wei Wang, Ze-Bo Jiang, Wei Li, Ju-Min Huang, Ya-Jia Xie, Cong Xu, Pei Liu,[...]. Pharmacol Res 2020
6
50

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
50

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.
Min Yuan, Li-Li Huang, Jian-Hua Chen, Jie Wu, Qing Xu. Signal Transduct Target Ther 2019
109
50

Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer.
Elaine Lai-Han Leung, Lian Xiang Luo, Ying Li, Zhong-Qiu Liu, Lan Lan Li, Dan Feng Shi, Ying Xie, Min Huang, Lin Lin Lu, Fu Gang Duan,[...]. Int J Cancer 2019
9
50

Luteolin modulates gene expression related to steroidogenesis, apoptosis, and stress response in rat LC540 tumor Leydig cells.
Roxanne Couture, Nathalie Mora, Sheiraz Al Bittar, Mustapha Najih, Mohamed Touaibia, Luc J Martin. Cell Biol Toxicol 2020
11
50

MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe,[...]. Oncogene 2017
55
50

The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
Jong Woo Lee, Yu Zhang, Kyung Jin Eoh, Roshan Sharma, Miguel F Sanmamed, Jenny Wu, Justin Choi, Hee Sun Park, Akiko Iwasaki, Edward Kaftan,[...]. J Thorac Oncol 2019
27
50

Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
Umasankar De, Ji Yeon Son, Yukyoung Jeon, Song-Yi Ha, Yu Jin Park, Sungpil Yoon, Ki-Tae Ha, Wahn Soo Choi, Byung Mu Lee, In Su Kim,[...]. Food Chem Toxicol 2019
23
50

Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.
Elise Alspach, Danielle M Lussier, Robert D Schreiber. Cold Spring Harb Perspect Biol 2019
96
50

PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade.
Marcel P Trefny, Monika Kaiser, Michal A Stanczak, Petra Herzig, Spasenija Savic, Mark Wiese, Didier Lardinois, Heinz Läubli, Franziska Uhlenbrock, Alfred Zippelius. Cancer Immunol Immunother 2020
20
50


Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma.
Elena Galvani, Piyushkumar A Mundra, Sara Valpione, Pablo Garcia-Martinez, Matthew Smith, Jonathan Greenall, Rohit Thakur, Beth Helmink, Miles C Andrews, Louis Boon,[...]. Nat Commun 2020
7
50

IL23-Producing Human Lung Cancer Cells Promote Tumor Growth via Conversion of Innate Lymphoid Cell 1 (ILC1) into ILC3.
Jaemoon Koh, Hye Young Kim, Youngha Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim, Ji-Eun Kim, Murim Choi, Won-Woo Lee, Yoon Kyung Jeon,[...]. Clin Cancer Res 2019
27
50

In situ antitumor vaccination: Targeting the tumor microenvironment.
Hanwen Li, Jiayun Yu, Yongyao Wu, Bin Shao, Xiawei Wei. J Cell Physiol 2020
6
50

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1.
Zhuoan Cheng, Chengtao Yu, Shaohua Cui, Hui Wang, Haojie Jin, Cun Wang, Botai Li, Meilin Qin, Chen Yang, Jia He,[...]. Nat Commun 2019
152
50

Flavonoids in Cancer Metastasis.
Alena Liskova, Lenka Koklesova, Marek Samec, Karel Smejkal, Samson Mathews Samuel, Elizabeth Varghese, Mariam Abotaleb, Kamil Biringer, Erik Kudela, Jan Danko,[...]. Cancers (Basel) 2020
38
50


MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.
Takahiro Maeda, Masayuki Hiraki, Caining Jin, Hasan Rajabi, Ashujit Tagde, Maroof Alam, Audrey Bouillez, Xiufeng Hu, Yozo Suzuki, Masaaki Miyo,[...]. Cancer Res 2018
74
50

The Therapeutic Potential of Apigenin.
Bahare Salehi, Alessandro Venditti, Mehdi Sharifi-Rad, Dorota Kręgiel, Javad Sharifi-Rad, Alessandra Durazzo, Massimo Lucarini, Antonello Santini, Eliana B Souto, Ettore Novellino,[...]. Int J Mol Sci 2019
172
50

Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology.
Benjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, Anna M Wu, Suzanne E Lapi, Jonathan E McConathy, Anna G Sorace, Asim K Bag, James M Markert, Jason M Warram. Theranostics 2019
13
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.